MedPath

Study held to see the effect of aparajita as a local application on dadru (Skin diseases)

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2022/05/042816
Lead Sponsor
ikita vilas Narnavar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Symptoms of Dadru (tinea) ââ?¬â?? Kandu, Daha, Raga ,Pidaka, Rookshata, Udgata Mandala.

2. Newly diagnosed patients of Dadru less than 6 month.

3. Mandala size less than 4 cm.

4. Tinea corporis, Tinea cruris

Exclusion Criteria

1. Patient with immunosuppressive medications.

2. Pregnant women and lactating women.

3. Patient suffering from any acute or chronic disorder,systemic or local disorder like DM,HTN,psoriasis,fractures ,TB,HIV,leprosy ,etc.

4. Tinea with complications, infectivefocus, tinea capitas, pedis, mannum,mandala size more than 4cm.

5. Patient associated with other types of Kushta.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of classical sign and symptoms of dadru after 21 days of interventionTimepoint: Improvement in classical sign and symptoms of dadru after 21 days of intervention
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath